Inducing the elimination of human pancreatic carcinoma (CFPAC-1) and glioblastoma (U87-MG) cell line in combination therapy with MSC-TRAIL in vitro (Coccè et al., 2020). The gene discussed is TNFSF10; the disease is exocrine pancreatic carcinoma.